| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/31/2003 | US20030143665 Calcium independent receptor of alpha-latrotoxin,characterization and uses thereof |
| 07/31/2003 | US20030143663 Process for preparing insulin compounds |
| 07/31/2003 | US20030143662 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 07/31/2003 | US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143651 Fret protease assays for clostridial toxins |
| 07/31/2003 | US20030143647 Anticancer vaccine and diagnostic methods and reagents |
| 07/31/2003 | US20030143633 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors |
| 07/31/2003 | US20030143632 Fusion proteins; tango genes; drug screening; competitive binding assay |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143615 Nucleic acid molecule containing a nucleotide sequence encoding CaEss1 (candida albicans) gene or having at least 70% homology; antiproliferative application |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143610 Methods for the treatment of metabolic disorders, including obesity and diabetes |
| 07/31/2003 | US20030143608 Drug response marker in beta-1 adrenergic receptor gene |
| 07/31/2003 | US20030143606 Nucleic acid comprising sequence segment of chemically pretreated DNA |
| 07/31/2003 | US20030143601 Methods and compositions for the detection of bovine pregnancy which utilize members of the 1-8 family of interferon inducible genes |
| 07/31/2003 | US20030143600 Extraction; use in identifying, diagnosing, monitoring, or evaluating cancer; gel electrophoresis, hybridization, blot analysis, liquid chromatography |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143590 Polynucleotide encoding a polypeptide; use in treating obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorder, schizophrenia, autism, neurodegenerative disorders |
| 07/31/2003 | US20030143583 Novel response element |
| 07/31/2003 | US20030143582 Polypeptides useful for regulating the cell cycle, proliferation, tumorigenesis, and genomic stability, mutants of such polypeptide useful in detecting abnormal cells and diagnosing diseases |
| 07/31/2003 | US20030143579 Inhibitors of apoptosis |
| 07/31/2003 | US20030143568 Methods and materials for characterizing and modulating interaction between heregulin and HER3 |
| 07/31/2003 | US20030143564 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody |
| 07/31/2003 | US20030143562 Structurally biased random peptide libraries based on different scaffolds |
| 07/31/2003 | US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 07/31/2003 | US20030143548 Determining genotype of the promoter region of a patient's 5-HTTP gene, and correlating with patient responsiveness; treating diarrhea-predominant irritable bowel syndrome |
| 07/31/2003 | US20030143546 Breast cancer transcription factor gene and uses |
| 07/31/2003 | US20030143545 Isolation of the lamin gamma2 gene in horses and its use in diagnostic junctional epidermolysis bullosa |
| 07/31/2003 | US20030143541 Isolated nucleic acid molecule encoding a polypeptide that mediates a detectable physiological or behvioral effect in mammals |
| 07/31/2003 | US20030143540 NF-kB Activating Gene |
| 07/31/2003 | US20030143533 Methods and compositions utilizing rad51 |
| 07/31/2003 | US20030143529 Detection and typing of human papillomavirus using PNA probes |
| 07/31/2003 | US20030143528 Vector for analayzing replication mechanism of rna virus and use thereof |
| 07/31/2003 | US20030143521 Physalia fluorescent proteins |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143243 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/31/2003 | US20030143242 For use in vaccination; prophylaxis and therapy of Helicobacter infection |
| 07/31/2003 | US20030143241 For inhibiting hepatitis E virus (HEV) infection |
| 07/31/2003 | US20030143240 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 07/31/2003 | US20030143239 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 07/31/2003 | US20030143238 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/31/2003 | US20030143237 Creating an immune response in the mammal to at least part of the amino acid sequence of an alpha fetoprotein molecule; where immune response comprises activating alpha fetoprotein peptide specific T lymphocytes against cancer cells |
| 07/31/2003 | US20030143236 For irreversibly inhibiting infectivity of a mammalian cell by a human rhinovirus |
| 07/31/2003 | US20030143233 For use in diagnosis, therapy |
| 07/31/2003 | US20030143227 For therapy of leukemia and lymphoblastoma, may also be used as imaging agents and diagnostic agents for detecting expression levels of the protein |
| 07/31/2003 | US20030143220 Hybrid immunoglobulins |
| 07/31/2003 | US20030143218 As target for drug screening |
| 07/31/2003 | US20030143217 For therapy of smooth muscle cell hyperplasia; cancer therapy |
| 07/31/2003 | US20030143210 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | US20030143203 Tumor therapy |
| 07/31/2003 | US20030143202 Anemia |
| 07/31/2003 | US20030143198 Method for preparing a physiologically active il-18 polypeptide |
| 07/31/2003 | US20030143196 To regulate an immune response in an animal |
| 07/31/2003 | US20030143193 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 07/31/2003 | US20030143192 Chemokine beta-7 |
| 07/31/2003 | US20030143191 For therapy and prophylaxis of immune disorders, hematopoietic disorders, autoimmune disorders, multiple sclerosis, Grave's disease, arthritis, rheumatoid arthritis, transplant rejection, neurodegenerative disorders, Alzheimer's disease |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | US20030143183 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 07/31/2003 | US20030143160 Administering conjugate of the entity and a light-generating moiety; immobilizing the subject within the detection field of a photodetector device; measuring photon emission with photodetectorl; constructing image |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2474763A1 Fiber shaft modifications for efficient targeting |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2474269A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | CA2474030A1 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 07/31/2003 | CA2473829A1 Use of tgf-.beta. antagonists to treat or to prevent chronic transplant rejection |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473746A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2473682A1 Tyrosine kinase inhibitors |
| 07/31/2003 | CA2473555A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/31/2003 | CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | CA2473376A1 Method for isolating nucleic acids and protein from a single sample |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472270A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 07/30/2003 | EP1331270A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 07/30/2003 | EP1331268A1 Novel proteins, genes encoding them and method of using the same |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331008A1 Process for the preparation of amylase inhibitor |
| 07/30/2003 | EP1330766A2 Method for designing protein libraries with altered immunogenicity |
| 07/30/2003 | EP1330646A1 Methods for detecting vasculopathies and tumors |
| 07/30/2003 | EP1330645A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 07/30/2003 | EP1330550A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 07/30/2003 | EP1330538A2 Cd36 as a heat shock protein receptor and uses thereof |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330531A2 Influenza virus vector for infection of dendritic cells |
| 07/30/2003 | EP1330525A2 Nod2 nucleic acids and proteins |
| 07/30/2003 | EP1330524A2 Novel human 7tm proteins and polynucleotides encoding the same |
| 07/30/2003 | EP1330523A2 Mammalian wnt polypeptide-5 |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330517A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |